David S Maxwell - Publications

Affiliations: 
1995-1997 Chemistry DuPont-Merck Pharmaceutical Company 
 1997-2003 Chemistry Encysive Pharmaceuticals 
 2003-2004 Chemistry Rice University, Houston, TX 
 2004-2008 Experimental Diagnostic Imaging The University of Texas M D Anderson Cancer Center, USA 
 2008-2014 Experimental Therapeutics The University of Texas M D Anderson Cancer Center, USA 
 2014- Institutional Analytics and Informatics The University of Texas M D Anderson Cancer Center, USA 
Area:
Computational Chemistry, Data Science
Website:
http://www.linkedin.com/in/david-maxwell-16999713

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Woodside DG, Tanifum EA, Ghaghada KB, Biediger RJ, Caivano AR, Starosolski ZA, Khounlo S, Bhayana S, Abbasi S, Craft JW, Maxwell DS, Patel C, Stupin IV, Bakthavatsalam D, Market RV, et al. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1. Scientific Reports. 8: 3733. PMID 29487319 DOI: 10.1038/s41598-018-21893-x  1
2016 Leonard PG, Satani N, Maxwell DS, Lin YH, Hammoudi N, Peng Z, Pisaneschi F, Link TM, Lee GR, Sun D, Prasad BAB, Di Francesco ME, Czako B, Asara JM, Wang YA, et al. SF2312 is a natural phosphonate inhibitor of enolase Nat Chem Biol. 12: 1053-1058. DOI: 10.1038/nchembio.2195  1
2014 Peng Z, Maxwell DS, Sun D, Bhanu Prasad BA, Schuber PT, Pal A, Ying Y, Han D, Gao L, Wang S, Levitzki A, Kapuria V, Talpaz M, Young M, Showalter HD, et al. Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I). Bioorganic & Medicinal Chemistry. 22: 1450-8. PMID 24457091 DOI: 10.1016/j.bmc.2013.12.048  1
2014 Peng Z, Maxwell DS, Sun D, Bhanu Prasad BA, Pal A, Wang S, Balatoni J, Ghosh P, Lim ST, Volgin A, Shavrin A, Alauddin MM, Gelovani JG, Bornmann WG. Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level. Bioorganic & Medicinal Chemistry. 22: 623-32. PMID 24280068 DOI: 10.1016/j.bmc.2013.10.040  1
2013 Maxwell DS, Sun D, Peng Z, Martin DV, Bhanu Prasad BA, Bornmann WG. Synthesis of a Macrocycle Based on Linked Amino Acid Mimetics (LAAM). Tetrahedron Letters. 54: 5799-5801. PMID 25110365 DOI: 10.1016/j.tetlet.2013.08.041  1
2013 Sun D, Bhanu Prasad BA, Schuber PT, Peng Z, Maxwell DS, Martin DV, Guo L, Han D, Kurihara H, Yang DJ, Gelovani JG, Powis G, Bornmann WG. Improved synthesis of 17β-hydroxy-16α-iodo-wortmannin, 17β-hydroxy-16α-iodoPX866, and the [(131)I] analogue as useful PET tracers for PI3-kinase. Bioorganic & Medicinal Chemistry. 21: 5182-7. PMID 23859776 DOI: 10.1016/j.bmc.2013.06.036  1
2013 Vanderslice P, Biediger RJ, Woodside DG, Brown WS, Khounlo S, Warier ND, Gundlach CW, Caivano AR, Bornmann WG, Maxwell DS, McIntyre BW, Willerson JT, Dixon RA. Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion. The Journal of Biological Chemistry. 288: 19414-28. PMID 23703610 DOI: 10.1074/jbc.M113.479634  1
2013 Arumugam T, Ramachandran V, Sun D, Peng Z, Pal A, Maxwell DS, Bornmann WG, Logsdon CD. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. Molecular Cancer Therapeutics. 12: 654-62. PMID 23303403 DOI: 10.1158/1535-7163.MCT-12-0771  1
2013 Angelo LS, Maxwell DS, Wu JY, Sun D, Hawke DH, McCutcheon IE, Slopis JM, Peng Z, Bornmann WG, Kurzrock R. Binding partners for curcumin in human schwannoma cells: biologic implications. Bioorganic & Medicinal Chemistry. 21: 932-9. PMID 23294827 DOI: 10.1016/j.bmc.2012.12.008  1
2011 Kapuria V, Levitzki A, Bornmann WG, Maxwell DS, Priebe W, Sorenson RJ, Showalter HD, Talpaz M, Donato NJ. A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination Cell Signal. 23: 2076-2085. DOI: 10.1016/j.cellsig.2011.08.002  1
2011 Peng Z, Pal A, Han D, Wang S, Maxwell DS, Levitzki A, Talpaz M, Donato NJ, Bornmann WG. Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma Bioorgan Med Chem. 19: 7194-7204. DOI: 10.1016/j.bmc.2011.09.057  1
2009 Najjar AM, Nishii R, Maxwell DS, Volgin A, Mukhopadhyay U, Bornmann WG, Tong W, Alauddin M, Gelovani JG. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 409-16. PMID 19223410 DOI: 10.2967/jnumed.108.058735  1
2009 Faderl S, Pal A, Bornmann WG, Albitar M, Maxwell DS, Van Q, Peng Z, Harris D, Liu Z, Hazan-Halevy I, Kantarjian HM, Estrov Z. Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells. Cancer Res. 69: 3910-3917. DOI: 10.1158/0008-5472.CAN-08-0034  1
2008 le Roux L, Volgin A, Maxwell, DS, Ishihara K, Gelovani J, Schellingerhout D. Optimizing Imaging of Three-Dimensional Multicellular Tumor Spheroids with Fluorescent Reporter Proteins Using Confocal Microscopy Molecular Imaging. 7: 214-221. DOI: 10.2310/7290.2008.00023  0.01
2007 Bommarius B, Maxwell, DS, Swimm, A, Leung, S, Corbett, A, Bornmann WG, Kalman, D. Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation Mol Microbiol. 63: 1748-1768. DOI: 10.1111/j.1365-2958.2007.05626.x  0.01
2006 Sankaranarayanapillai M, Tong WP, Maxwell DS, Pal A, Pang J, Bornmann WG, Gelovani JG, Ronen SM. Detection of histone deacetylase inhibition by noninvasive magnetic resonance spectroscopy. Molecular Cancer Therapeutics. 5: 1325-34. PMID 16731766 DOI: 10.1158/1535-7163.MCT-05-0494  1
2006 O'Brian CA, Chu F, Bornmann WG, Maxwell DS. Protein kinase Calpha and epsilon small-molecule targeted therapeutics: a new roadmap to two Holy Grails in drug discovery? Expert Review of Anticancer Therapy. 6: 175-86. PMID 16445370 DOI: 10.1586/14737140.6.2.175  1
2006 Pal, A, Glekas A, Doubrovin M, Balatoni J, Beresten T, Maxwell D, Soghomonyan S, Shavrin A, Ageyeva L, Finn R, Larson SM, Bornmann WG, and Gelovani JG.. Molecular Imaging of EGFR Kinase Activity in Tumors with 124I-Labeled Small Molecular Tracer and Positron Emission Tomography Molecular Imaging and Biology. 8: 262-277. DOI: 10.1007/s11307-006-0049-0  1
2002 You TJ, Maxwell DS, Kogan TP, Chen Q, Li J, Kassir J, Holland GW, Dixon RA. A 3D structure model of integrin alpha 4 beta 1 complex: I. Construction of a homology model of beta 1 and ligand binding analysis. Biophysical Journal. 82: 447-57. PMID 11751331 DOI: 10.1016/S0006-3495(02)75409-X  1
1999 Chen Q, Wu C, Maxwell D, Krudy GA, Dixon RAF, and You TJ. 3D QSAR analysis of in vitro binding affinity and selectivity of 3-isoxazolylsulfonylaminothiophenes as endothelin receptor antagonists Quantitative Structure-Activity Relationships. 18: 124-133. DOI: 10.1002/(SICI)1521-3838(199906)18:2<124::AID-QSAR124>3.0.CO;2-7  1
1996 Jorgensen WL, Maxwell DS, Tirado-Rives, J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids Journal of the American Chemical Society. 118: 11225-11236. DOI: 10.1021/ja9621760  1
1995 Maxwell DS, Tirado-Rives J, Jorgensen WL. A comprehensive study of the rotational energy profiles of organic systems by ab initio MO theory, forming a basis for peptide torsional parameters Journal of Computational Chemistry. 16: 984-1010. DOI: 10.1002/jcc.540160807  1
1993 Tirado-Rives J, Maxwell DS, Jorgensen WL. Molecular dynamics and Monte Carlo simulations favor the a-helical form for alanine-based peptides in water Journal of the American Chemical Society. 115: 11590-11593. DOI: 10.1021/ja00077a066  1
Show low-probability matches.